ARS Pharmaceuticals, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
ARS Pharmaceuticals, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2020 to Q4 2023.
  • ARS Pharmaceuticals, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $2.95M, a 93.8% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $2.95M +$1.43M +93.8% Dec 31, 2023 10-K 2024-03-21
Q4 2022 $1.52M +$373K +32.5% Dec 31, 2022 10-K 2024-03-21
Q4 2021 $1.15M +$206K +21.9% Dec 31, 2021 10-K 2024-03-21
Q4 2020 $941K Dec 31, 2020 10-K 2023-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.